or
forgot password

    • cancer clinical trials in wyoming

    • Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

    Jackson, Wyoming
    Mycoses, Candidiasis, Invasive, Candidemia
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Prostate Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Welch Cancer Center
    Sheridan, Wyoming 82801
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Brain and Central Nervous System Tumors
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Neuroendocrine Carcinoma
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Malignant Mesothelioma
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lymphoma
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Rocky Mountain Oncology
    Casper, Wyoming 82609
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Rocky Mountain Oncology

    Trial Locations
    Rocky Mountain Oncology
    Welch Cancer Center at Sheridan Memorial Hospital
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific